Company profile for Stallergenes Greer

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Headquartered in London (UK), Stallergenes Greer is a fully integrated global biopharmaceutical company specializing in the diagnosis and treatment of allergies. Capitalizing on a very strong heritage in both the US and Europe, we are leveraging our complementary capabilities in every area of our activities from research to professional healthcare partnerships. Stallergenes Greer is a global healthcare company specializing in...
Headquartered in London (UK), Stallergenes Greer is a fully integrated global biopharmaceutical company specializing in the diagnosis and treatment of allergies. Capitalizing on a very strong heritage in both the US and Europe, we are leveraging our complementary capabilities in every area of our activities from research to professional healthcare partnerships. Stallergenes Greer is a global healthcare company specializing in the diagnosis and treatment of allergies through the development and commercialization of allergy immunotherapy (AIT) products and services.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Tower bridge House, St Katharine’s Way, London, E1W 1DD
Telephone
Telephone
+44 20 7239 4508
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251030498975/en/Staloral-Birch-Phase-III-Study-Successfully-Meets-Primary-Endpoint-Demonstrating-Efficacy-in-Children-and-Adolescents

BUSINESSWIRE
30 Oct 2025

https://www.businesswire.com/news/home/20250903612776/en/Stallergenes-Greer-and-Nuance-Pharma-Enter-Exclusive-Long-term-Partnership-for-Actair-Sublingual-Immunotherapy-Tablet-for-the-Treatment-of-House-Dust-Mite-Allergy-in-China

BUSINESSWIRE
03 Sep 2025

https://www.businesswire.com/news/home/20250730591660/en/Stallergenes-Greer-Announces-Palforzia-Featured-on-The-Balancing-Act-Airing-on-Lifetime-TV

BUSINESSWIRE
30 Jul 2025

https://www.businesswire.com/news/home/20250702309702/en/Transition-of-Promotional-Activities-for-Allergen-Immunotherapy-Drug-Actair-in-Japan

BUSINESSWIRE
03 Jul 2025

https://www.businesswire.com/news/home/20250611950731/en/Stallergenes-Greer-Showcases-Developments-in-Respiratory-and-Food-Allergy-Care-at-EAACI-2025

BUSINESSWIRE
12 Jun 2025

https://www.businesswire.com/news/home/20250228357515/en

BUSINESSWIRE
28 Feb 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty